Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 19Breast Neoplasms 12Brain Neoplasms 11Agnosia 7Neoplasms 6Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Lung Neoplasms 4Pituitary Neoplasms 3Pain 3Inflammation 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Thrombosis 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1

Interventions

Saline Solution 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Elderly × Dexmedetomidine × Clear all
NCT06030804 2025-07-31

Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Peking University First Hospital

Phase NA Recruiting
4,532 enrolled

Elderly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡